These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 12621452)

  • 1. A neovascularized organoid derived from retrovirally engineered bone marrow stroma leads to prolonged in vivo systemic delivery of erythropoietin in nonmyeloablated, immunocompetent mice.
    Eliopoulos N; Al-Khaldi A; Crosato M; Lachapelle K; Galipeau J
    Gene Ther; 2003 Mar; 10(6):478-89. PubMed ID: 12621452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human-compatible collagen matrix for prolonged and reversible systemic delivery of erythropoietin in mice from gene-modified marrow stromal cells.
    Eliopoulos N; Lejeune L; Martineau D; Galipeau J
    Mol Ther; 2004 Oct; 10(4):741-8. PubMed ID: 15451458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Erythropoietin delivery by genetically engineered bone marrow stromal cells for correction of anemia in mice with chronic renal failure.
    Eliopoulos N; Gagnon RF; Francois M; Galipeau J
    J Am Soc Nephrol; 2006 Jun; 17(6):1576-84. PubMed ID: 16672321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neo-organoid of marrow mesenchymal stromal cells secreting interleukin-12 for breast cancer therapy.
    Eliopoulos N; Francois M; Boivin MN; Martineau D; Galipeau J
    Cancer Res; 2008 Jun; 68(12):4810-8. PubMed ID: 18559528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Postnatal bone marrow stromal cells elicit a potent VEGF-dependent neoangiogenic response in vivo.
    Al-Khaldi A; Eliopoulos N; Martineau D; Lejeune L; Lachapelle K; Galipeau J
    Gene Ther; 2003 Apr; 10(8):621-9. PubMed ID: 12692590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced engraftment of EPO-transduced human bone marrow stromal cells transplanted in a 3D matrix in non-conditioned NOD/SCID mice.
    Daga A; Muraglia A; Quarto R; Cancedda R; Corte G
    Gene Ther; 2002 Jul; 9(14):915-21. PubMed ID: 12085239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coupling erythropoietin secretion to mesenchymal stromal cells enhances their regenerative properties.
    Copland IB; Jolicoeur EM; Gillis MA; Cuerquis J; Eliopoulos N; Annabi B; Calderone A; Tanguay JF; Ducharme A; Galipeau J
    Cardiovasc Res; 2008 Aug; 79(3):405-15. PubMed ID: 18397963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Continuous delivery of human and mouse erythropoietin in mice by genetically engineered polymer encapsulated myoblasts.
    Régulier E; Schneider BL; Déglon N; Beuzard Y; Aebischer P
    Gene Ther; 1998 Aug; 5(8):1014-22. PubMed ID: 10326023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human cytidine deaminase as an ex vivo drug selectable marker in gene-modified primary bone marrow stromal cells.
    Eliopoulos N; Al-Khaldi A; Beauséjour CM; Momparler RL; Momparler LF; Galipeau J
    Gene Ther; 2002 Apr; 9(7):452-62. PubMed ID: 11938460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonviral gene delivery of erythropoietin by mesenchymal stromal cells.
    Scheibe F; Gladow N; Mergenthaler P; Tucker AH; Meisel A; Prockop DJ; Priller J
    Gene Ther; 2012 May; 19(5):550-60. PubMed ID: 21956691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Local ex vivo gene therapy with bone marrow stromal cells expressing human BMP4 promotes endosteal bone formation in mice.
    Zhang XS; Linkhart TA; Chen ST; Peng H; Wergedal JE; Guttierez GG; Sheng MH; Lau KH; Baylink DJ
    J Gene Med; 2004 Jan; 6(1):4-15. PubMed ID: 14716672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone marrow-derived mesenchymal stem cells: isolation, expansion, characterization, viral transduction, and production of conditioned medium.
    Gnecchi M; Melo LG
    Methods Mol Biol; 2009; 482():281-94. PubMed ID: 19089363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Organoids direct systemic expression of erythropoietin in mice.
    Descamps V; Blumenfeld N; Perricaudet M; Beuzard Y; Kremer EJ
    Gene Ther; 1995 Aug; 2(6):411-7. PubMed ID: 7584116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mesenchymal stromal cells lose their immunosuppressive potential after allotransplantation.
    Prigozhina TB; Khitrin S; Elkin G; Eizik O; Morecki S; Slavin S
    Exp Hematol; 2008 Oct; 36(10):1370-6. PubMed ID: 18619727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mesenchymal stromal cells genetically engineered to overexpress IGF-I enhance cell-based gene therapy of renal failure-induced anemia.
    Kucic T; Copland IB; Cuerquis J; Coutu DL; Chalifour LE; Gagnon RF; Galipeau J
    Am J Physiol Renal Physiol; 2008 Aug; 295(2):F488-96. PubMed ID: 18524862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retroviral vector-producing mesenchymal stem cells for targeted suicide cancer gene therapy.
    Uchibori R; Okada T; Ito T; Urabe M; Mizukami H; Kume A; Ozawa K
    J Gene Med; 2009 May; 11(5):373-81. PubMed ID: 19274675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene therapy using TRAIL-secreting human umbilical cord blood-derived mesenchymal stem cells against intracranial glioma.
    Kim SM; Lim JY; Park SI; Jeong CH; Oh JH; Jeong M; Oh W; Park SH; Sung YC; Jeun SS
    Cancer Res; 2008 Dec; 68(23):9614-23. PubMed ID: 19047138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Matrix-mediated retention of adipogenic differentiation potential by human adult bone marrow-derived mesenchymal stem cells during ex vivo expansion.
    Mauney JR; Volloch V; Kaplan DL
    Biomaterials; 2005 Nov; 26(31):6167-75. PubMed ID: 15913765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improvement of mouse beta-thalassemia upon erythropoietin delivery by encapsulated myoblasts.
    Dalle B; Payen E; Regulier E; Deglon N; Rouyer-Fessard P; Beuzard Y; Aebischer P
    Gene Ther; 1999 Feb; 6(2):157-61. PubMed ID: 10435099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidermal growth factor receptor-transfected bone marrow stromal cells exhibit enhanced migratory response and therapeutic potential against murine brain tumors.
    Sato H; Kuwashima N; Sakaida T; Hatano M; Dusak JE; Fellows-Mayle WK; Papworth GD; Watkins SC; Gambotto A; Pollack IF; Okada H
    Cancer Gene Ther; 2005 Sep; 12(9):757-68. PubMed ID: 15832173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.